On Nov 4, 2021 Primmune Therapeutics closed a Series A round and raised $8,400,000 from investors, featuring lead investors . About the company: Primmune Therapeutics […]
Series A – Clade Therapeutics
On Nov 3, 2021 Clade Therapeutics closed a Series A round and raised $87,000,000 from Bristol Myers Squibb, Emerson Collective, LifeSci Venture Partners, Syncona Partners […]
Series A – Parthenon Therapeutics
On Nov 3, 2021 Parthenon Therapeutics closed a Series A round and raised $65,000,000 from Alexandria Venture Investments, Breakout Ventures, Creacion Ventures, KdT Ventures, Northpond […]
Series A – Sanity Group
On Nov 3, 2021 Sanity Group closed a Series A round and raised $3,500,000 from Casa Verde Capital, featuring lead investors Casa Verde Capital. About […]
Series B – Antios Therapeutics
On Nov 3, 2021 Antios Therapeutics closed a Series B round and raised $75,000,000 from Adage Capital Management, Aisling Capital, Altium Capital, Amzak Health Investors, […]
Series B – Prilenia
On Nov 3, 2021 Prilenia closed a Series B round and raised $43,000,000 from ALS Investment Fund, Amplitude Venture Capital, Forbion Capital Partners, Morningside Venture […]
Series B – Hallow
On Nov 3, 2021 Hallow closed a Series B round and raised $40,000,000 from Contrary, Drive Capital, Narya Capital, Peter Thiel, Scott Malpass, Susa Ventures, […]
Series B – Notable
On Nov 3, 2021 Notable closed a Series B round and raised $100,000,000 from F-Prime Capital, Greylock, ICONIQ Growth, Oak HC/FT, featuring lead investors ICONIQ […]
Series B – BrainCheck
On Nov 3, 2021 BrainCheck closed a Series B round and raised $10,000,000 from Next Coast Ventures, Nueterra Capital, S3 Ventures, SelectQuote Insurance Services, Tensility […]
Series A – Nitrase Therapeutics
On Nov 2, 2021 Nitrase Therapeutics closed a Series A round and raised $7,000,000 from AbbVie Biotech Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Dementia […]
